L Roźéwicka

414 total citations
31 papers, 334 citations indexed

About

L Roźéwicka is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, L Roźéwicka has authored 31 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in L Roźéwicka's work include Drug-Induced Hepatotoxicity and Protection (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Antioxidant Activity and Oxidative Stress (4 papers). L Roźéwicka is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Antioxidant Activity and Oxidative Stress (4 papers). L Roźéwicka collaborates with scholars based in Poland, Czechia and United States. L Roźéwicka's co-authors include L Samochowiec, J Wójcicki, Barbara Wiszniewska, Zygmunt Juzyszyn, Maria Laszczyńska, Mariola Marchlewicz, Małgorzata Piasecka, Rafał Kurzawa, Bernard C. Dominiak and Marek Droździk and has published in prestigious journals such as Atherosclerosis, Phytotherapy Research and Journal of Pharmacy and Pharmacology.

In The Last Decade

L Roźéwicka

29 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Roźéwicka Poland 8 152 86 50 47 46 31 334
Alice L. Murkies Australia 8 168 1.1× 89 1.0× 133 2.7× 26 0.6× 27 0.6× 11 1.0k
Mary P. Carpenter United States 13 169 1.1× 117 1.4× 125 2.5× 9 0.2× 46 1.0× 15 429
M. P. Bansal India 13 183 1.2× 26 0.3× 77 1.5× 158 3.4× 83 1.8× 21 441
Veda Diwadkar‐Navsariwala United States 7 232 1.5× 144 1.7× 128 2.6× 62 1.3× 11 0.2× 7 415
J. Klvanová Slovakia 12 104 0.7× 53 0.6× 66 1.3× 15 0.3× 7 0.2× 25 421
Issam Chargui Tunisia 11 104 0.7× 34 0.4× 69 1.4× 96 2.0× 14 0.3× 15 464
Saad A. Noeman United States 7 78 0.5× 41 0.5× 103 2.1× 18 0.4× 9 0.2× 12 465
J. Liggins United Kingdom 4 149 1.0× 88 1.0× 118 2.4× 19 0.4× 8 0.2× 6 649
V. Bhuvaneswari India 7 53 0.3× 214 2.5× 121 2.4× 19 0.4× 12 0.3× 14 347
B. Velmurugan India 14 61 0.4× 228 2.7× 173 3.5× 24 0.5× 14 0.3× 17 474

Countries citing papers authored by L Roźéwicka

Since Specialization
Citations

This map shows the geographic impact of L Roźéwicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Roźéwicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Roźéwicka more than expected).

Fields of papers citing papers by L Roźéwicka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Roźéwicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Roźéwicka. The network helps show where L Roźéwicka may publish in the future.

Co-authorship network of co-authors of L Roźéwicka

This figure shows the co-authorship network connecting the top 25 collaborators of L Roźéwicka. A scholar is included among the top collaborators of L Roźéwicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Roźéwicka. L Roźéwicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laszczyńska, Maria, et al.. (2009). Evaluation of spermatozoa of the rat in hyperprolactinaemia induced by Metoclopramide. Andrologia. 24(2). 101–108. 2 indexed citations
2.
Kamińska, Barbara, et al.. (2009). Zinc Content in Epididymal Spermatozoa of Metoclopramide-Treated Rats. Andrologia. 19(6). 677–683. 7 indexed citations
3.
Wójcicki, Maciej, Marek Droździk, Tadeusz Sulikowski, et al.. (2000). Pharmacokinetics of intravenously administered digoxin and histopathological picture in rabbits with experimental bile duct obstruction. European Journal of Pharmaceutical Sciences. 11(3). 215–222. 5 indexed citations
4.
Wójcicki, J, Anna Machoy‐Mokrzyńska, L Samochowiec, et al.. (1996). Effect of lecithin on the development of experimental atherosclerosis in rabbits. Phytomedicine. 2(3). 199–204. 1 indexed citations
5.
Wójcicki, J, Tadeusz Sulikowski, Maciej Wójcicki, et al.. (1995). Pharmacokinetics of lidocaine and its major metabolite — monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction. European Journal of Drug Metabolism and Pharmacokinetics. 20(2). 119–123. 1 indexed citations
6.
Wójcicki, J, L Samochowiec, Barbara Wiszniewska, et al.. (1994). Ginkgo biloba extract inhibits the development of experimental atherosclerosis in rabbits. Phytomedicine. 1(1). 33–38. 1 indexed citations
7.
Marchlewicz, Mariola, et al.. (1993). Effect of long-term exposure to lead on testis and epididymis in rats.. PubMed. 31(2). 55–62. 35 indexed citations
8.
Droździk, Marek, et al.. (1993). Pharmacokinetics of multiple-dose administered gentamicin to unilaterally nephrectomized rabbits.. PubMed. 65 Suppl. 83–9. 3 indexed citations
9.
Wójcicki, J, et al.. (1992). Essential phospholipids modify immunological functions and reduce experimental atherosclerosis in rabbits. Atherosclerosis. 93(1-2). 7–16. 6 indexed citations
10.
Wójcicki, J, et al.. (1991). Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis. 87(1). 9–16. 154 indexed citations
11.
Dominiak, Bernard C. & L Roźéwicka. (1990). Actin filaments in epididymal cells of rat and their presumed function. Folia Histochemica et Cytobiologica. 28(3). 2 indexed citations
12.
Laszczyńska, Maria, L Roźéwicka, & Jan Lubiński. (1989). Ultrastructure of epithelial cells in rat's epididymal caput in experimental hyperprolactinemia induced by metoclopramide.. PubMed. 27(4). 219–26. 1 indexed citations
13.
Roźéwicka, L, et al.. (1985). Isolation technique and identification of epithelial cells from efferent ductules of the rat epididymis.. PubMed. 23(4). 201–7. 4 indexed citations
14.
Roźéwicka, L, et al.. (1978). Effect of essential phospholipids on the lipid content in the liver and myocardium of rats fed a high-fat diet.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(4). 249–55.
15.
Roźéwicka, L, et al.. (1976). Aberrations of meiotic chromosomes induced in mice with insecticides.. PubMed. 35(3). 361–8. 5 indexed citations
17.
Roźéwicka, L, et al.. (1975). Influence of orally administered sulfur on activity of oxidative and hydrolytic enzymes in guinea pig kidneys.. PubMed. 34(3). 219–30. 2 indexed citations
18.
Wojcicki, Janet M., et al.. (1973). The influence of dipyridamol on changes in the heart induced with posterior pituitary extract.. PubMed. 21(4). 653–60. 1 indexed citations
19.
Wójcicki, J, et al.. (1973). Effects of "essential" phospholipids (EPL) on experimental ethanol-induced cardiomyopathy.. PubMed. 23(8). 1070–2. 1 indexed citations
20.
Roźéwicka, L. (1968). The mitochondria and the Golgi apparatus in the cells of olfactory epithelium and olfactory glands in mammals.. PubMed. 16(4). 401–15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026